top of page

Dr. Heidi Noels and Dr. Yvonne Döring receive the W.H. Hauss Award from the DGAF

19-21 April 2018

Dr. Heidi Noels from the Institute for Molecular Cardiovascular Research at RWTH Aachen University together with Dr. Yvonne Döring from the Institute for Prophylaxis and Epidemiology of Circulatory Diseases at LMU Munich together received the DGAF W.H. Hauss Award 2018 from the German Society for Atherosclerosis Research (DGAF) during the 32nd Annual Meeting of the DGAF in Rauischholzhausen, Germany. They were awarded for their publication "Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence From Mouse and Human Studies." (Circulation. 2017; 136: 388-403). In this work it could be shown that vascular CXCR4 has an atheroprotective function by maintaining the arterial integrity and preserving the endothelial barrier function. In addition, CXCR4 stabilizes a contractile smooth muscle cell phenotype. Targeted enhancement of these CXCR4-mediated protective functions could open up novel therapeutic options in the treatment of atherosclerosis.

The award was sponsored by a long-standing active member of the DGAF, Prof. Dr. Winfried März.

Project area Z

Administrative project

Robert Werner Mertens

MD student

University Hospital RWTH Aachen

Department of Internal Medicine

Project: The role of incretin hormone GLP-2 in septic cardiomyopathy

PI: Michael Lehrke

Robert Werner Mertens

MD student

University Hospital RWTH Aachen

Department of Internal Medicine

Project: The role of incretin hormone GLP-2 in septic cardiomyopathy

PI: Michael Lehrke

Consortium

Summerschool 2018

Mechanisms of Cardiovascular Complications

in Chronic Kidney Disease

Logo

Flyer

The SFB/TRR219 is supported by the German Research Foundation (DFG)

Project-ID 322900939

Aachen Conference on Cardiorenal Disease and Diabetes

SFB/TRR219
Nov 15
1 min read

Also in 2025, SFB/TRR219 under lead of Prof. Dr. Nikolaus Marx organized the “Aachen Conference on Cardiorenal Disease and Diabetes”. At the meeting, various aspects in the field were presented with a focus on cardiovascular disease and the impact of chronic kidney disease and diabetes.

In addition to international experts in the field, the meeting also included a special SFB/TRR219 session with updates from our own consortium, as well as a poster session supporting ongoing cooperations and networking. On the last day, the meeting integrated a clinical education session to discuss implementations in daily clinical practice.

Comments

bottom of page